Organon & Co. (OGN)
7.385
+0.32
(+4.60%)
USD |
NYSE |
Feb 13, 16:00
7.38
0.00 (0.00%)
After-Hours: 20:00
Organon Free Cash Flow : 598.00M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 13.05B |
| Amphastar Pharmaceuticals, Inc. | 111.00M |
| Plus Therapeutics, Inc. | -15.78M |
| Geron Corp. | -132.68M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 264.00M |
| Cash from Investing (Quarterly) | -115.00M |
| Cash from Financing (Quarterly) | -76.00M |
| Free Cash Flow Per Share (Quarterly) | 0.5716 |
| Free Cash Flow to Equity (Quarterly) | 217.00M |
| Free Cash Flow to Firm (Quarterly) | 235.26M |
| Free Cash Flow Yield | 31.09% |